Surgical therapy for acute superior mesenteric artery embolism. 2004

Hakan Bingol, and Nazif Zeybek, and Faruk Cingöz, and Ahmet T Yilmaz, and Harun Tatar, and Derviş Sen
Department of Cardiovascular Surgery, Gülhane Military Medical Academy, Etlik 06018 Ankara, Turkey. hbingol@gata.edu.tr

BACKGROUND Acute mesenteric artery embolism has a high rate of morbidity and mortality. Early diagnosis and appropriate treatment are the most important factors associated with morbidity and mortality. METHODS During the period between 1997 and 2002, 24 patients underwent superior mesenteric artery embolectomy. The patients were divided into three groups according to the onset of symptoms and operation time. Group I (n = 12) patients were operated on in the first 6 hours after onset of symptoms; group II (n = 9) patients were operated on between 6 and 12 hours after onset; and group III (n = 3) patients underwent embolectomy after 12 hours. Low-dose (5 to 10 mg) local tissue-type plasminogen activator (t-PA) administration directly into the superior mesenteric artery was an additional procedure with the embolectomy in all patients. RESULTS The macroscopic view of the intestine was normal in 15 patients (12 patients in group I and 3 patients in group II) 30 minutes after the administration of local t-PA. Segmental resection was necessary in 4 patients in group II. Extended resection was necessary in 2 patients in group II and 3 patients in group III, and all of the patients died during the early postoperative period. CONCLUSIONS We suggest that explorative laparotomy should be done in patients with sudden abdominal pain, nausea, vomiting, mild leukocytosis, and metabolic acidosis who have previous valvular heart disease or atrial fibrillation. Ultimately, selective low dose t-PA (5 to 10 mg) administration reduces the length of intestinal portion to be resected.

UI MeSH Term Description Entries
D008641 Mesenteric Vascular Occlusion Obstruction of the flow in the SPLANCHNIC CIRCULATION by ATHEROSCLEROSIS; EMBOLISM; THROMBOSIS; STENOSIS; TRAUMA; and compression or intrinsic pressure from adjacent tumors. Rare causes are drugs, intestinal parasites, and vascular immunoinflammatory diseases such as PERIARTERITIS NODOSA and THROMBOANGIITIS OBLITERANS. (From Juergens et al., Peripheral Vascular Diseases, 5th ed, pp295-6) Mesenteric Vascular Occlusions,Occlusion, Mesenteric Vascular,Occlusions, Mesenteric Vascular,Vascular Occlusion, Mesenteric,Vascular Occlusions, Mesenteric
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010959 Tissue Plasminogen Activator A proteolytic enzyme in the serine protease family found in many tissues which converts PLASMINOGEN to FIBRINOLYSIN. It has fibrin-binding activity and is immunologically different from UROKINASE-TYPE PLASMINOGEN ACTIVATOR. The primary sequence, composed of 527 amino acids, is identical in both the naturally occurring and synthetic proteases. Alteplase,Plasminogen Activator, Tissue-Type,T-Plasminogen Activator,Tissue-Type Plasminogen Activator,Actilyse,Activase,Lysatec rt-PA,TTPA,Tisokinase,Tissue Activator D-44,Lysatec rt PA,Lysatec rtPA,Plasminogen Activator, Tissue,Plasminogen Activator, Tissue Type,T Plasminogen Activator,Tissue Activator D 44,Tissue Type Plasminogen Activator
D004617 Embolism Blocking of a blood vessel by an embolus which can be a blood clot or other undissolved material in the blood stream. Embolus,Embolisms
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014421 Turkey Country in Southeastern Europe and Southwestern Asia bordering the Black Sea, between Bulgaria and Georgia, and bordering the Aegean Sea and the Mediterranean Sea, between Greece and Syria. The capital is Ankara. Turkiye
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

Hakan Bingol, and Nazif Zeybek, and Faruk Cingöz, and Ahmet T Yilmaz, and Harun Tatar, and Derviş Sen
December 2013, Zhonghua yi xue za zhi,
Hakan Bingol, and Nazif Zeybek, and Faruk Cingöz, and Ahmet T Yilmaz, and Harun Tatar, and Derviş Sen
April 1963, Surgery, gynecology & obstetrics,
Hakan Bingol, and Nazif Zeybek, and Faruk Cingöz, and Ahmet T Yilmaz, and Harun Tatar, and Derviş Sen
April 1973, The Medical journal of Australia,
Hakan Bingol, and Nazif Zeybek, and Faruk Cingöz, and Ahmet T Yilmaz, and Harun Tatar, and Derviş Sen
November 1987, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
Hakan Bingol, and Nazif Zeybek, and Faruk Cingöz, and Ahmet T Yilmaz, and Harun Tatar, and Derviş Sen
February 1972, Journal of the Oslo city hospitals,
Hakan Bingol, and Nazif Zeybek, and Faruk Cingöz, and Ahmet T Yilmaz, and Harun Tatar, and Derviş Sen
January 1957, Burma medical journal,
Hakan Bingol, and Nazif Zeybek, and Faruk Cingöz, and Ahmet T Yilmaz, and Harun Tatar, and Derviş Sen
January 1965, Polski przeglad chirurgiczny,
Hakan Bingol, and Nazif Zeybek, and Faruk Cingöz, and Ahmet T Yilmaz, and Harun Tatar, and Derviş Sen
May 1993, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica,
Hakan Bingol, and Nazif Zeybek, and Faruk Cingöz, and Ahmet T Yilmaz, and Harun Tatar, and Derviş Sen
March 2005, Journal of vascular and interventional radiology : JVIR,
Hakan Bingol, and Nazif Zeybek, and Faruk Cingöz, and Ahmet T Yilmaz, and Harun Tatar, and Derviş Sen
July 1965, Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti,
Copied contents to your clipboard!